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INTRODUCTION
Cardiac conduction abnormalities after heart surgery are ob-
served in 17% to 34% of patients. Transient brady-
arrhythmias resolve themselves in the first days after sur-
gery, but persistent conduction disturbances requiring per-
manent pacemaker implantation (PPI) occur in 0.4–8.5% of
patients undergoing conventional heart surgery, depending
on surgery type and can reach even higher frequencies after
TAVI (Meimoun et al., 2002; Berdajs et al., 2008; Merin et
al., 2009; Moraca et al., 2009; Schurr et al., 2010;
Al-Ghamdi et al., 2016; Mangieri et al., 2018).
The incidence of postoperative PPI has a tendency to de-
crease, because of better understanding of the mechanisms
of possible injury to the conduction system of the heart dur-
ing surgery. Certain technological improvements to the pro-
cedures and to the design of implantable devices have facili-
tated this reduction (Nardi et al., 2010; Al-Ghamdi et al.,
2016). On the other hand, the overall number of PPI after
cardiac procedures has increased due to the advent of
TAVI. PPI after TAVI is reported in even up to > 20% pa-
tients depending on the prosthesis used (Mangieri et al.,
2018). Unfortunately, in contrary to some beliefs, PPI is
not a harmless procedure as it may increase morbidity and
postoperative hospital stay (Merin et al., 2009).
The aim of our study was to determine the incidence of PPI
after conventional cardiac surgery and to compare the inci-
dence of PPI after various conventional open-heart surgical
procedures and TAVI, as well as to assess its influence on
intrahospital outcomes.
MATERIALS AND METHODS
This is a single-centre retrospective study. We reviewed all
patients who underwent open heart surgery at Pauls Stradiòð
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Permanent pacemaker implantation (PPI) after open heart surgery is required in 0.4–8.5% of pa-
tients. The aim of our study was to determine the incidence of PPI after cardiac surgery at Pauls
Stradiòð Clinical University Hospital and to assess its influence on intrahospital outcomes. This
was a single-centre retrospective study. We reviewed all patients who underwent either open
heart surgery or transcatheter aortic valve implantation (TAVI) between the years 2015 and 2017.
Included were all patients with PPI postoperatively before discharge. We compared the patient
demographics, and perioperative state, incidence of PPI and intrahospital stay among groups. Af-
ter cardiac surgery a total of 135 (4.2%) patients received a PPI. The PPI incidence was highest
in the tricuspid valve intervention group — 8.8% followed by aortic valve replacement (AVR) pa-
tients with 3.3%. After TAVI incidence of PPI was 4.0% after Sapien valve and 8% after
CoreValve implantations, respectively. Incidence of PPI after TAVI with the Sapien valve was not
significantly higher when compared to conventional AVR, but it was significantly higher after TAVI
with CoreValve. Regardless of the initial procedure a need for PPI significantly increased the total
length of hospital stay.
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Clinical University Hospital between the years 2015 and
2017, in total 3242 patients. Included in this study were all
patients with PPI postoperatively before discharge. Also, all
patients undergoing transfemoral TAVI using either the Ed-
wards Sapien or Medtronic Corevalve systems were as-
sessed — a total of 174 and 50 patients, respectively. We
compared the patient demographics, and perioperative state,
incidence of PPI and intrahospital stay among groups of pa-
tients undergoing isolated CABG, aortic valve replacement,
any tricuspid valve intervention and TAVI. For statistical
analysis, the Chi-Square or Fisher’s Exact Test, normal ap-
proximation (Wald) was used; p values < 0.05 were consid-
ered as statistically significant. The study was conducted af-
ter it was approved by the research ethics board in our
hospital.
RESULTS
From the 3242 patients after conventional cardiac surgery,
135 (4.2%) patients received a PPI. The mean age of PPI
patients was 68.5 ± 10.5 years. The most common indica-
tion for PPI was complete atrioventricular block in 59
(43.7%), sick sinus syndrome with symptomatic bradycar-
dia in 25 (18.5%), and atrial fibrillation (AF) with a slow
ventricular rate in 41 (30.4%). Other causes for PPI were re-
corded in 10 (7.4%) patients — six having second-degree
atrioventricular block and four ventricular tachycardia and
receiving an implantable cardioverter defibrillator (Fig. 1).
It has to be noted that sick sinus syndrome with significant
bradycardia in these patients was not diagnosed before sur-
gery.
As expected, the lowest incidence of PPI was observed in
the group of patients undergoing isolated CABG with only
two cases (0.2%; CI 0.0–0.8%). The incidence of PPI in the
group of conventional AVR patients was 3.3% (CI 2.0–4.6).
Among conventional surgery patients, the PPI rate was
higher only in the tricuspid valve intervention group —
8.8%; CI 6.9–10.9%. In all patients receiving PPI the total
length of hospital stay was significantly longer compared
with the patients not requiring PPI. The longest hospital
stay was for the patients having a tricuspid valve procedure.
For them it also took the longest until PPI after the initial
surgery. These results with additional data on patient groups
can be seen in Table 1.
After TAVI, 11 patients received PPI, seven of them after
Edwards Sapien implantation with a PPI incidence of 4.0%
and four after Medtronic Corevalve, with an incidence of
8%. In both of these groups patient mean age was signifi-
cantly older than that in the conventional AVR group: 82.6
± 5.8 in Corevalve and 83.2 ± 4.3 in Sapien groups, respec-
tively. The length of hospital stay in these groups increased
from 10.4 days to 16.4 in the Sapien group and from 8.2
days to 14.1 in the Corevalve group if receiving PPI (Table
1).
For all surgical procedures combined mean time from initial
surgery to PPI when developing a complete AV block was
significantly shorter —5.0 ± 3.4 days compared to 7.7 ± 3.2
days for other indications (p < 0.05). Analysis of most com-
mon indications for PPI in studied surgical groups is sum-
marised in Table 2. As complete AV block altogether was
the most common indication for PPI, we performed a risk
analysis to determine patient and procedure factors increas-
ing the likelihood of an AV block in our series. The factors
having the most significant impact were preoperative right
bundle branch block (OR 2.86 [1.12 – 7.27], p = 0.02), in-
tervention on the aortic valve (OR 2.93 [1.16 – 7.43], p =
0.02) and heavy calcinosis of the aortic valve annulus (OR
2.53 [1.03 – 6.23], p = 0.04).
DISCUSSION
In our series the overall intrahospital PPI rate after open
heart surgery was 4.2%, which is similar to published re-
sults from other institutions and registries (Al-Ghamdi et
al., 2016). We observed the highest need for pacemaker im-
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Fig. 1. Most common indications for permanent pacemaker implantation
after conventional open cardiac surgery.
T a b l e 1
PROPORTION OF PATIENTS RECEIVING PERMANENT PACEMAKER IMPLANTATION, THEIR AGE, TIME UNTIL PACEMAKER IMPLANTA-
TION AND TOTAL LENGTH OF STAY IN STUDIED SURGICAL AND TAVI PATIENT GROUPS
CABG TV procedure AVR TAVI Sapien TAVI CoreValve
Patients: total/ with PPI 1006/2 803/38 722/24 174/7 50/4
Age at the time of the surgery, mean values ±SD 68.4 ± 10.4 69.4 ± 8.7 69.5 ± 11.4 83.2 ± 4.3 82.6 ± 5.8
Days to PPI after surgery, mean values ±SD 7.1 ± 7.3 7.8 ± 4.8 5.7 ± 3.4 3.2 ± 1.8 4.3 ± 2.5
Total length of stay in days, patients without PPI/with PPI 9.4/17.6 10.3/17.8 9.2/16.2 10.4/16.4 8.2/14.1
AVR, aortic valve replacement; CABG, coronary artery bypass grafting; PPI, permanent pacemaker implantation; SD, standard deviation; TAVI,
transcatheter aortic valve implantation; TV, tricuspid valve. For total length of stay Student's t-test showed p < 0.05 for all analysed patient groups.
plantation in the group of patients undergoing tricuspid
valve interventions, reaching even 8.8%. This can be ex-
plained by the proximity of the AV node to the fibrous anu-
lus of the tricuspid valve and hence high likelihood to dam-
age while passing through surgical stiches in order to repair
or replace the tricuspid valve (Fig. 2), even though this is a
well-known anatomical fact and has been taken in to ac-
count when developing valve repair techniques and devices.
Annuloplasty rings are incomplete rings, trying to avoid the
area with the highest risk to damage the conduction system.
Still, the risks cannot be fully mitigated, because the con-
duction system is invisible to the surgeon’s eye and there
exist anatomical variations of the location of the AV node.
Hence, avoiding stitches at a certain area does not 100%
prevent from developing a complete AV block. The next
procedure most commonly requiring PPI is AVR, with
3.3% of cases, which corresponds well to the results pub-
lished elsewhere (Limongelli et al. 2003; Schurr et al.
2010). With aortic valve procedures the situation is similar,
as making sutures for aortic valve replacement or repair can
directly damage elements of the conduction system, which
are located in the area of the right coronary sinus, passing
through the membranaceous septum (Fig. 2). The same
mechanism works with TAVI; here damage to the conduc-
tion may be caused by the radial force of the TAVI valves
pushing against LVOT, against septum and hence damaging
atrio-ventricular signal conduction (Mangieri et al., 2018).
As TAVI valves rely on their radial force as the only
mechanism of fixation in the aortic annulus, this is an in-
born problem of the procedure. The risk of PPI in TAVI can
be reduced only by avoiding to implant the valve too deep
ventricle-wise. As for some of the valves the stents are very
long and designed to be located partially in the LVOT, this
is a serious problem. One of the valves with a very tall pro-
file and long stent is the Medtronic CoreValve. This valve
has been reported to have high PPI rates. Our study showed
similar results to previously reported ones, and patients with
CoreValve implantations demonstrated significantly higher
PPI rates of 8% when compared both to conventional AVR
with 3.3% and TAVI with Edwards Sapien valve with 4%
PPI rates, respectively. This data corresponds well with pre-
viously published results, where the PPI incidence after
CoreValve ranged between 6% and even as high as 30%
(Erkapic et al., 2012; Mangieri et al., 2018).
The most common indication for PPI in our series was com-
plete AV block both for conventionally operated and TAVI
patients (see Table 2). As mentioned previously, patients
with complete AV block received PPI significantly earlier
in comparison to patients with other indications — 5.0 ± 3.4
days compared to 7.7 ± 3.2, respectively. This can be ex-
plained by the higher risk of managing these patients with-
out a PPI, because in case of temporary pacemaker lead fail-
ure these patients would be left with a risk of asystole,
compared to other forms of bradyarrhythmias with at least
some if even very slow base heart rate. It has to be noted
that there is a wide variation in regard to recommended tim-
ing of PPI after cardiac surgery procedures, which ranges
from 3 to 21 days after appearance of an AV block (Schurr
et al., 2010). This wide variety in the time to PPI can be ex-
plained by observations that the rhythm disturbances are
temporary and potentially due to postoperative edema of
cardiac tissue, which may resolve with time. Hence, in
some situations with lower degree of AV blockade or slow
sinus rhythm, it is reasonable to postpone PPI. In contrast,
it has been shown that complete AV block, especially after
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T a b l e 2
MOST COMMON INDICATIONS FOR PPI IN STUDIED SURGICAL AND TAVI PATIENT GROUPS
Indication AVR CABG TV procedure TAVI Sapien TAVI CoreValve
Complete AV block, n (%) 16 (66.7%) 0 26 (36.6%) 4 (57.1%) 3 (75%)
Sick sinus node syndrome, n (%) 5 (16.7%) 1 (50.0%) 5 (7.2%) 0 0
AF brady form, n (%) 0 1 (50.0%) 34 (49.3%) 3 (42.9%) 1 (25%)
AF, atrial fibrillation; AV, atrioventricular; AVR, aortic valve replacement; CABG, coronary artery bypass grafting; PPI, permanent pacemaker implantation;
TAVI, transcatheter aortic valve implantation; TV, tricuspid valve.
Fig. 2. Electrical conduction system of the heart: 1) Sinoatrial node;
2) Atrioventricular node; 3) Bundle of His; 4) Left bundle branch; 5) Left
posterior fascicle; 6) Left-anterior fascicle; 7) Left ventricle; 8) Ventricular
septum; 9) Right ventricle; 10) Right bundle branch.
Copyright: Patrick J. Lynch, medical illustrator; C. Carl Jaffe, MD, cardio-
logist. https://creativecommons.org/licenses/by/2.5/
aortic valve procedures resolves very rarely (Schurr et al.,
2010) and can be a serious risk for the patients after cardiac
surgery, justifying earlier PPI. We report time to PPI as low
as 3.2 ± 1.8 days after TAVI with the Sapien valve ranging
till 7.8 ± 4.8 days after tricuspid valve interventions. This
certainly marks a well pronounced tendency to implant a
permanent device earlier in the TAVI cohort, which com-
pares well with previously published data (Nazif et al.
2015; Tichelbäcker et al. 2018).
CONCLUSIONS
In our centre, patients undergoing heart surgery required a
PPI in approximately 4.2% of all cases. The risk of PPI was
particularly higher after procedures where TV was in-
volved, followed by AVR. Incidence of PPI after TAVI
with the Sapien valve was not significantly higher when
compared to conventional AVR, but it was significantly in-
creased after TAVI with CoreValve. Regardless of the ini-
tial procedure, a need for PPI significantly increased the to-
tal length of hospital stay.
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PASTÂVÎGA ELEKTROKARDIOSTIMULATORA IMPLANTÂCIJAS BIEÞUMS PÇC SIRDS ÍIRURÌIJAS OPERÂCIJÂM: VIENA
CENTRA PIEREDZE
Pastâvîga elektrokardiostimulatora (EKS) implantâcija pçc atvçrtâm sirds operâcijâm nepiecieðama vidçji 0,4–8,5% pacientu. Ðî pçtîjuma
mçríis bija noteikt pastâvîga EKS implantâcijas bieþumu pçc atvçrta tipa sirds operâcijâm Latvijas Kardioloìijas centrâ, kâ arî novçrtçt tâ
ietekmi uz intrahospitâlajiem rezultâtiem. Ðis ir viena centra retrospektîvs pçtîjums. Mçs apskatîjâm visus pacientus, kuriem tika veikta vai
nu atvçrta sirds operâcija, vai transkatetra aortas vârstuïa implantâcija (TAVI) no 2015. lîdz 2017. gadam. Tika iekïauti visi pacienti ar no
jauna implantçtu EKS pirms izrakstîðanâs no stacionâra. Mçs salîdzinâjâm pacientu demogrâfiskos datus, perioperatîvo stâvokli, EKS
implantâcijas bieþumu un intrahospitâlâs uzturçðanâs ilgumu starp pacientu grupâm. Pçc sirds íirurìijas kopâ 135 (4,2%) pacientiem bija
nepiecieðama EKS implantâcija. Vislielâkâ pastâvîga EKS incidence bija trikuspidâlâ vârstuïa intervences grupâ — 8,8%, kam sekoja aortas
vârstuïa protezçðanas (AVR) pacienti ar 3,3% incidenci. Pçc TAVI pastâvîga EKS implantâcija bija nepiecieðama 4,0% gadîjumu pçc
Sapien protçzes un 8,0% gadîjumu pçc CoreValve implantâcijas. Salîdzinot ar konvencionâlu AVR, pastâvîga EKS implantâcijas incidence
pçc Sapien protçzes nebija nozîmîgi lielâka, savukârt, pçc CoreValve incidence bija nozîmîgi lielâka. Neatkarîgi no iniciâlâs procedûras,
nepiecieðamîba pçc EKS implantâcijas pçcoperâcijas periodâ nozîmîgi pagarinâja kopçjo hospitalizâcijas laiku.
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